GRND — what changed in the latest 10-Q
A section-by-section comparison of GRND's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-08 vs the prior 10-Q · 2025-11-06
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +50 | −66 | ~27 | 21 |
| Market risk (Item 3) | Text added/removed | +3 | −4 | ~1 | 1 |
| Controls & procedures | Text added/removed | 0 | −1 | ~1 | 2 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 3 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +2 | −6 | ~1 | 3 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-08
We generated $129.9 million and $93.9 million of revenue for the three months ended March 31, 2026, and 2025, respectively, representing a period-over-period growth of 38.3% as compared to the three-month period in 2025.
We had 1.4 million and 1.2 million Average Paying Users, for the three months ended March 31, 2026, and 2025, respectively, representing a period-over-period growth of 18.6% as compared to the three-month period in 2025.
On January 23, 2025, we provided notice that we would redeem all of our outstanding warrants, which consisted of (i) 18,560,000 private placement warrants; (ii) 13,799,825 public warrants; (iii) 2,500,000 forward purchase warrants; and (iv) 2,500,000 backstop warrants, on February 24, 2025. After we…
an aggregate of 27,315,105 shares of our common stock at an exercise price of $11.50 per share, for aggregate cash proceeds to us of $314.1 million. In addition, 9,469,634 warrants were exercised on a cashless basis in exchange for the issuance of 3,418,518 shares of our common stock. At the conclus…
(1)See “Non-GAAP Financial Measures” below for additional information and reconciliations of non-GAAP financial measures to the most comparable GAAP financial measures.
Text removed vs the prior filing · source: 10-Q · 2025-11-06
We generated $115.8 million and $89.3 million of revenue for the three months ended September 30, 2025 and 2024, respectively, and we generated $313.9 million and $247.0 million of revenue for the nine months ended September 30, 2025 and 2024, respectively, representing a period-over-period growth o…
We had 1.3 million and 1.1 million Average Paying Users, for the three months ended September 30, 2025 and 2024, respectively, and we had 1.2 million and 1.1 million Average Paying Users, for the nine months ended September 30, 2025 and 2024, respectively, representing a period-over-period growth of…
On January 23, 2025, we provided notice to the registered holders of our outstanding warrants that we would redeem the warrants at a redemption price of $0.10 per warrant at 5:00 p.m. New York City time on February 24, 2025 (the “Redemption Date”). In connection with the redemption, warrant holders …
After our announcement that we would redeem all of our outstanding warrants, and prior to the conclusion of the redemption notice period at 5:00 p.m. New York City time on the Redemption Date, an aggregate of: (i) 9,469,634 warrants were exercised on a cashless basis in exchange for the issuance of …
Consolidated Results for Nine Months Ended September 30, 2025 and 2024
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-05-08
We conduct business in certain foreign markets. As a result, we are exposed to foreign exchange risk related to certain currencies, primarily the Euro and British Pound.
For the three months ended March 31, 2026, and 2025, international revenue accounted for 43.0% and 41.2% of our consolidated revenue, respectively. We have exposure to foreign currency exchange risk related to transactions carried out in a currency other than our functional currency, the U.S. dollar…
Historically, we have not hedged any foreign currency exposures. We have performed a sensitivity analysis as of March 31, 2026, and 2025. A hypothetical 10% change in Euro and British Pound, relative to the U.S. dollar, would have changed revenue by $3.0 million and $2.1 million for the three months…
Text removed vs the prior filing · source: 10-Q · 2025-11-06
As of September 30, 2025, our cash, cash equivalent, and restricted cash had a fair value of $6.9 million. Of that amount, a total $1.4 million was invested in money market funds. The primary purpose of these investments has been to preserve principal until the cash is required to, among other thing…
We conduct business in certain foreign markets. As a result, we are exposed to foreign exchange risk related to certain currencies, primary the Euro and British Pound.
For the nine months ended September 30, 2025 and 2024, international revenue accounted for 42.9% and 43.1% of our consolidated revenue, respectively. We have exposure to foreign currency exchange risk related to transactions carried out in a currency other than our functional currency, the U.S. doll…
Historically, we have not hedged any foreign currency exposures. We have performed a sensitivity analysis as of September 30, 2025 and 2024. A hypothetical 10% change in Euro and British Pound, relative to the U.S. dollar, would have changed revenue by $2.8 million and $2.3 million for the nine mont…
Controls & procedures
Text removed vs the prior filing · source: 10-Q · 2025-11-06
our Chief Executive Officer and Chief Financial Officer have concluded that as of September 30, 2025, our disclosure controls and procedures were effective at a reasonable assurance level.
Other information
Text added vs the prior filing · source: 10-Q · 2026-05-08
Zachary Katz, Chief Legal Officer, General Counsel & Head of Global Affairs
Includes 172,000 shares of common stock subject to restricted stock units (“RSUs”) previously granted to Mr. Katz that may vest and be released on or prior to July 17, 2026. The actual number of shares that will be released to Mr. Katz in respect of such RSUs and sold pursuant to the Rule 10b5-1 tra…
Text removed vs the prior filing · source: 10-Q · 2025-11-06
On November 5, 2025, James Fu Bin Lu notified the Company of his resignation, effective immediately, from the Board. Mr. Lu’s resignation was not the result of a disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. Prior to his resignation Mr. Lu …
In connection with the transition, the Board appointed J. Michael Gearon, Jr. to serve as Lead Independent Director. In addition, the Board appointed Daniel Brooks Baer and Meghan Stabler to serve as members of the Nominating Committee, appointed Mr. Baer as chair of the Nominating Committee, and ap…
Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a written plan adopted on September 17, 2024 and modified on March 13, 2025 that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. As modified, the written…
Includes 75,019 shares of common stock subject to restricted stock units (“RSUs”) previously granted to Mr. Balance that may vest and be released on or prior to December 1, 2025. The actual number of shares that will be released to Mr. Balance in respect of such RSUs and sold pursuant to the Rule 10…
Effective October 1, 2025, Ms. Mehta-Krantz has transitioned out of the role of Chief Financial Officer.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice